fluoxetine has been researched along with methylphenidate in 57 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.75) | 18.7374 |
| 1990's | 7 (12.28) | 18.2507 |
| 2000's | 16 (28.07) | 29.6817 |
| 2010's | 28 (49.12) | 24.3611 |
| 2020's | 5 (8.77) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, MH; Acree, WE; Ibrahim, A | 1 |
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Choi, Y; Raymer, BK | 1 |
| Salzman, C | 1 |
| Jerome, L | 1 |
| Cox, BM; Izenwasser, S; Werling, LL | 1 |
| Delashaw, JB; Dement, WC; Foutz, AS; Guilleminault, C | 1 |
| Alexoff, DA; Chen, R; Dewey, SL; Ding, YS; Fowler, JS; Gatley, SJ; Pan, D | 1 |
| Cole, JO; Diamond, L; Pillay, SS; Stoll, AL; Workum, SB | 1 |
| Findling, RL | 1 |
| Dogin, JW; Findling, RL | 1 |
| Castaneda, R; Hardy, M; Levy, R; Trujillo, M | 1 |
| DeVane, CL; Ferrell, RE; Sallee, FR | 1 |
| Booij, J; De Bruin, K; Gunning, WB; Lavalaye, J; Reneman, L | 1 |
| Hause, S; Huether, G; Moll, GH; Rothenberger, A; Rüther, E | 1 |
| Fukushima, S; Hall, FS; Kobayashi, H; Numachi, Y; Shen, HW; Sora, I; Uhl, GR; Yamashita, M | 1 |
| Borycz, J; Ferré, S; Quiroz, C; Volkow, ND; Zapata, A | 1 |
| Deutsch, HM; Kim, DI; Schweri, MM; Ye, X | 1 |
| Bolaños, CA; Grausam, KB; Henderson, RP; Kinka, DW; Maffeo, ML; Powers, KD; Willey, MD | 1 |
| Barton, R | 1 |
| Purper-Ouakil, D | 1 |
| Coskun, M; Zoroglu, S | 1 |
| Vitiello, B | 1 |
| Ibi, D; Koike, H; Mizoguchi, H; Nabeshima, T; Nagai, T; Nitta, A; Takuma, K; Yamada, K; Yoneda, Y | 1 |
| Marinelli, M; Steiner, H; Van Waes, V | 1 |
| Beverley, J; Marinelli, M; Steiner, H; Van Waes, V | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Parise, EM; Warren, BL; Weakley, SK; Wright, KN | 1 |
| Fitzgerald, PJ; Hefner, KR; Holmes, A; Ihne, JL | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Brookshire, BR; Jones, SR | 1 |
| Johansen, SS; Nielsen, MK | 1 |
| Beverley, JA; Carr, B; Steiner, H; Van Waes, V | 1 |
| Hall, FS; Kasahara, Y; Kobayashi, H; Numachi, Y; Sakakibara, Y; Sora, I; Uchiumi, O; Uhl, GR; Yamashita, M; Yoshida, S | 1 |
| Beverley, J; Steiner, H; Van Waes, V; Vandrevala, M | 1 |
| Calahorro, F; Izquierdo, PG; Ruiz-Rubio, M | 1 |
| Alcantara, LF; Bolaños-Guzmán, CA; Iñiguez, SD; Parise, EM; Warren, BL | 1 |
| Boer, F; Bottelier, MA; Bouziane, C; de Ruiter, MB; Denys, D; Geurts, HM; Klomp, A; Lindauer, RJ; Reitsma, HB; Reneman, L; Rijsman, R; Ruhé, HG; Schouw, ML; Schrantee, AG; Tamminga, HG | 1 |
| Bolaños-Guzmán, CA; Steiner, H; Van Waes, V; Warren, BL | 1 |
| Arora, GS; Arora, HK; Najjar, F; Sidhu, J | 1 |
| Kasahara, Y; Kubo, Y; Sora, I | 1 |
| Beverley, JA; Ehrlich, S; Steiner, H; Van Waes, V | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Cevallos, J; DeShields, S; Izquierdo, A; Pozos, H; Rodriguez, J; Stolyarova, A; Torre, Ade L | 1 |
| Alter, D; Beverley, JA; Bolaños-Guzmán, CA; Patel, R; Steiner, H | 1 |
| Blakely, RD; Carroll, FI; Davis, GL; Gowrishankar, R; Gresch, PJ; Hahn, MK; Katamish, RM; Peart, R; Rabil, MJ; Stewart, A | 1 |
| Adil, KJ; Cheong, JH; Han, SH; Jeon, SJ; Kim, HJ; Kim, HY; Kim, R; Kwon, KJ; Mabunga, DFN; Park, D; Ryu, O; Shin, CY; Valencia, S | 1 |
| Marion, M; Moon, C; Steiner, H; Thanos, PK | 1 |
| Blum, K; Connor, C; Hadjiargyrou, M; Hammond, N; Komatsu, D; McCarthy, M; Senior, D; Steiner, H; Thanos, PK; Watts, S | 1 |
| Areikat, N; Chirokikh, AA; Connor, C; Duque, E; Hadjiargyrou, M; Jones, R; Komatsu, DE; Thanos, PK; Uddin, SMZ | 1 |
| Alhambra, DP; Kim, C; Kim, SJ; Lee, DY; Lee, J; Lee, S; Lee, YH; Park, J; Park, RW; Shin, Y; Tan, EH; Yang, SJ | 1 |
8 review(s) available for fluoxetine and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
Monoamine oxidase inhibitors and atypical antidepressants.
Topics: Aged; Antidepressive Agents; Bupropion; Depressive Disorder; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Psychiatric Status Rating Scales; Trazodone | 1992 |
Psychopharmacology of ADHD: children and adolescents.
Topics: Adolescent; Age Factors; Amphetamines; Antidepressive Agents, Tricyclic; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Child; Cyclohexanols; Dextroamphetamine; Drug Administration Schedule; Fluoxetine; Humans; Methylphenidate; Monoamine Oxidase Inhibitors; Pemoline; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1998 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
[Use of psychotropic drugs in children].
Topics: Adolescent; Age Factors; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Controlled Clinical Trials as Topic; Depressive Disorder; Drug Prescriptions; Enuresis; Fluoxetine; Humans; Mental Disorders; Meta-Analysis as Topic; Methylphenidate; Obsessive-Compulsive Disorder; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Time Factors | 2008 |
Life-long consequences of juvenile exposure to psychotropic drugs on brain and behavior.
Topics: Aging; Animals; Behavior, Animal; Brain; Child; Disease Models, Animal; Fluoxetine; Humans; Methylphenidate; Psychotropic Drugs | 2014 |
[Analysis of dopamine transporter knockout mice as an animal model of AD/HD].
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Humans; Methylphenidate; Mice; Mice, Knockout | 2013 |
2 trial(s) available for fluoxetine and methylphenidate
| Article | Year |
|---|---|
Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series.
Topics: Adult; Aged; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Methylphenidate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 1996 |
The effects of Psychotropic drugs On Developing brain (ePOD) study: methods and design.
Topics: Adolescent; Adult; Animals; Antidepressive Agents; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Child; Cross-Sectional Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Methylphenidate; Problem Solving; Research Design; Young Adult | 2014 |
47 other study(ies) available for fluoxetine and methylphenidate
| Article | Year |
|---|---|
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Pharmacotherapy of eating and behavioral problems.
Topics: Child; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Male; Methylphenidate; Pemoline; Prader-Willi Syndrome | 1991 |
Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex.
Topics: Animals; Cerebral Cortex; Cocaine; Corpus Striatum; Dopamine; Dopamine Antagonists; Fluoxetine; In Vitro Techniques; Kinetics; Male; Methylphenidate; Nalidixic Acid; Naphthyridines; Neurotransmitter Uptake Inhibitors; Norepinephrine; Nucleus Accumbens; Olfactory Bulb; Piperazines; Rats; Rats, Inbred Strains | 1990 |
Monoaminergic mechanisms and experimental cataplexy.
Topics: Animals; Antidepressive Agents, Tricyclic; Biogenic Amines; Cataplexy; Dogs; Female; Fluoxetine; Haloperidol; Humans; Male; Methylphenidate; Monoamine Oxidase Inhibitors; Physostigmine; Pimozide; Propranolol; Sleep, REM; Sodium Oxybate | 1981 |
Binding of bromine-substituted analogs of methylphenidate to monoamine transporters.
Topics: Animals; Binding, Competitive; Bromine; Carrier Proteins; Chromatography, High Pressure Liquid; Cocaine; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Magnetic Resonance Spectroscopy; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Mice; Microdialysis; Motor Activity; Nerve Tissue Proteins; Norepinephrine; Paroxetine; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Structure-Activity Relationship; Tomography, Emission-Computed, Single-Photon | 1994 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.
Topics: Adult; Algorithms; Amphetamines; Antidepressive Agents, Second-Generation; Attention Deficit Disorder with Hyperactivity; Bupropion; Central Nervous System Stimulants; Cocaine-Related Disorders; Delayed-Action Preparations; Diagnosis, Dual (Psychiatry); Drug Therapy, Combination; Fluoxetine; Humans; Methylphenidate; Outcome Assessment, Health Care; Pemoline | 2000 |
Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency.
Topics: Antipruritics; Attention Deficit Disorder with Hyperactivity; Child; Cytochrome P-450 CYP2D6; Dopamine Agents; Epilepsy, Absence; Fatal Outcome; Fluoxetine; Humans; Male; Methylphenidate; Polymorphism, Genetic; Polypharmacy; Promethazine; Selective Serotonin Reuptake Inhibitors; Tourette Syndrome | 2000 |
Addition of a 5-HT receptor agonist to methylphenidate potentiates the reduction of [123I]FP-CIT binding to dopamine transporters in rat frontal cortex and hippocampus.
Topics: Animals; Biogenic Monoamines; Carrier Proteins; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; Hippocampus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methylphenidate; Nerve Tissue Proteins; Neurons; Prefrontal Cortex; Quipazine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Tropanes | 2001 |
Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.
Topics: Animals; Brain Chemistry; Carrier Proteins; Central Nervous System Stimulants; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Kinetics; Ligands; Membrane Glycoproteins; Membrane Transport Proteins; Membranes; Mesencephalon; Methylphenidate; Neostriatum; Nerve Tissue Proteins; Paroxetine; Piperazines; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2001 |
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Inhibition, Psychological; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors | 2006 |
5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.
Topics: Animals; Central Nervous System Stimulants; Dopamine; Dose-Response Relationship, Drug; Extracellular Space; Fluoxetine; Male; Methamphetamine; Methylphenidate; Microdialysis; Motor Activity; Nucleus Accumbens; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Receptor Agonists | 2008 |
Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Citalopram; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Male; Methylphenidate; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2007 |
Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Behavior, Animal; Conditioning, Operant; Fluoxetine; Food Preferences; Male; Maze Learning; Mental Disorders; Methylphenidate; Rats; Rats, Sprague-Dawley; Swimming | 2008 |
Tactile and visual hallucinations in a child with methylphenidate and fluoxetine combination.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Dopamine Uptake Inhibitors; Drug Combinations; Fluoxetine; Hallucinations; Humans; Male; Methylphenidate; Selective Serotonin Reuptake Inhibitors | 2008 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Behavioral abnormality and pharmacologic response in social isolation-reared mice.
Topics: Aggression; Animals; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Cognition; Emotions; Fluoxetine; Male; Methylphenidate; Mice; Mice, Inbred ICR; Social Behavior; Social Isolation; Stress, Psychological | 2009 |
Fluoxetine potentiates methylphenidate-induced gene regulation in addiction-related brain regions: concerns for use of cognitive enhancers?
Topics: Animals; Antidepressive Agents, Second-Generation; Autoradiography; Behavior, Animal; Brain; Central Nervous System Stimulants; Drug Synergism; Early Growth Response Protein 1; Exploratory Behavior; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2010 |
Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.
Topics: Analysis of Variance; Animals; Autoradiography; Citalopram; Corpus Striatum; Dopamine Uptake Inhibitors; Early Growth Response Protein 1; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Methylphenidate; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2010 |
Juvenile administration of concomitant methylphenidate and fluoxetine alters behavioral reactivity to reward- and mood-related stimuli and disrupts ventral tegmental area gene expression in adulthood.
Topics: Animals; Anxiety; Cyclic AMP Response Element-Binding Protein; Extracellular Signal-Regulated MAP Kinases; Fluoxetine; Gene Expression; Male; Methylphenidate; Phosphorylation; Rats; Rats, Sprague-Dawley; Reward; Signal Transduction; TOR Serine-Threonine Kinases; Ventral Tegmental Area | 2011 |
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Body Weight; Central Nervous System Stimulants; Chlordiazepoxide; Corticosterone; Disease Models, Animal; Emotions; Exploratory Behavior; Fluoxetine; Light; Lithium Chloride; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Restraint, Physical; Stress, Psychological; Swimming | 2012 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine.
Topics: Animals; Antidepressive Agents, Second-Generation; Depression; Drug Administration Schedule; Female; Fluoxetine; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Neuropsychological Tests | 2012 |
Simultaneous determination of 25 common pharmaceuticals in whole blood using ultra-performance liquid chromatography-tandem mass spectrometry.
Topics: Analgesics; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Chromatography, High Pressure Liquid; Clopenthixol; Fluoxetine; Histamine Antagonists; Humans; Limit of Detection; Linear Models; Methotrimeprazine; Methylphenidate; Mianserin; Mirtazapine; Pharmaceutical Preparations; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2012 |
Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
Topics: Animals; Autoradiography; Central Nervous System Stimulants; Corpus Striatum; Drug Synergism; Dynorphins; Early Growth Response Protein 1; Enkephalins; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Neural Pathways; Neurons; Neuropeptides; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Substance P; Substantia Nigra | 2012 |
Impaired cliff avoidance reaction in dopamine transporter knockout mice.
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Behavior, Animal; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; Impulsive Behavior; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins; Reflex, Startle; Sensory Gating | 2013 |
Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.
Topics: Animals; Carrier Proteins; Cocaine; Corpus Striatum; Dopamine Uptake Inhibitors; Drug Combinations; Drug Synergism; Early Growth Response Protein 1; Fluoxetine; Homer Scaffolding Proteins; Male; Methylphenidate; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2014 |
Neuroligin modulates the locomotory dopaminergic and serotonergic neuronal pathways of C. elegans.
Topics: Animals; Caenorhabditis elegans; Cell Adhesion Molecules, Neuronal; Dopamine; Dopamine Uptake Inhibitors; Fluoxetine; Locomotion; Methylphenidate; Neural Pathways; Selective Serotonin Reuptake Inhibitors; Serotonin | 2013 |
Effects of psychotropic drugs on second messenger signaling and preference for nicotine in juvenile male mice.
Topics: Animals; Cocaine; Conditioning, Psychological; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Fluoxetine; Gene Expression; Male; MAP Kinase Signaling System; Methylphenidate; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Psychotropic Drugs; RNA, Messenger; Second Messenger Systems; Space Perception; Time Factors; Ventral Tegmental Area | 2014 |
Tactile hallucinations with fluoxetine and methylphenidate.
Topics: Central Nervous System Stimulants; Child; Drug Therapy, Combination; Fluoxetine; Hallucinations; Humans; Male; Methylphenidate; Selective Serotonin Reuptake Inhibitors | 2014 |
Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.
Topics: Animals; Corpus Striatum; Drug Synergism; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Neural Pathways; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists | 2015 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Sex differences, learning flexibility, and striatal dopamine D1 and D2 following adolescent drug exposure in rats.
Topics: Age Factors; Animals; Animals, Newborn; Central Nervous System Stimulants; Conditioning, Operant; Corpus Striatum; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Fluoxetine; Learning; Male; Methamphetamine; Methylphenidate; Rats; Rats, Long-Evans; Receptors, Dopamine D1; Receptors, Dopamine D2; Selective Serotonin Reuptake Inhibitors; Sex Characteristics | 2016 |
The 5-HT1B serotonin receptor regulates methylphenidate-induced gene expression in the striatum: Differential effects on immediate-early genes.
Topics: Animals; Corpus Striatum; Dose-Response Relationship, Drug; Drug Synergism; Early Growth Response Protein 1; Fluoxetine; Gene Expression Regulation; Genes, Immediate-Early; Homer Scaffolding Proteins; Locomotion; Male; Methylphenidate; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Receptor, Serotonin, 5-HT1B; Serotonin 5-HT1 Receptor Agonists | 2017 |
Serotonin transporter inhibition and 5-HT
Topics: Animals; Behavior, Animal; Cocaine; Conditioning, Classical; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Fluoxetine; Locomotion; Methylphenidate; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Transgenic; Neostriatum; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins | 2019 |
Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fluoxetine; Growth and Development; Methylphenidate; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Open Field Test; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Sleep | 2021 |
Fluoxetine Potentiates Oral Methylphenidate-Induced Gene Regulation in the Rat Striatum.
Topics: Administration, Oral; Animals; Corpus Striatum; Dopamine Uptake Inhibitors; Drug Synergism; Fluoxetine; Gene Expression Regulation; Male; Methylphenidate; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors | 2021 |
Combined Chronic Oral Methylphenidate and Fluoxetine Treatment During Adolescence: Effects on Behavior.
Topics: Animals; Anxiety; Attention Deficit Disorder with Hyperactivity; Fluoxetine; Methylphenidate; Rats; Selective Serotonin Reuptake Inhibitors | 2023 |
Combined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development.
Topics: Animals; Body Weight; Fluoxetine; Male; Methylphenidate; Rats; Rats, Sprague-Dawley; Weight Gain | 2023 |
Safety outcomes of selective serotonin reuptake inhibitors in adolescent attention-deficit/hyperactivity disorder with comorbid depression:
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cohort Studies; Depression; Escitalopram; Fluoxetine; Humans; Methylphenidate; Selective Serotonin Reuptake Inhibitors; Tic Disorders | 2023 |